Norma R. Moore

1.1k total citations
16 papers, 834 citations indexed

About

Norma R. Moore is a scholar working on Cancer Research, Hematology and Epidemiology. According to data from OpenAlex, Norma R. Moore has authored 16 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Hematology and 5 papers in Epidemiology. Recurrent topics in Norma R. Moore's work include Protease and Inhibitor Mechanisms (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Norma R. Moore is often cited by papers focused on Protease and Inhibitor Mechanisms (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Norma R. Moore collaborates with scholars based in United Kingdom, Netherlands and India. Norma R. Moore's co-authors include N. A. Booth, Bruce Bennett, Andrew J.G. Simpson, Nuala A. Booth, Nicola J. Mutch, Neil A. R. Gow, Louise Thomas, A. John Simpson, Derek Cruickshank and Teake Kooistra and has published in prestigious journals such as CHEST Journal, Molecular Microbiology and British Journal of Pharmacology.

In The Last Decade

Norma R. Moore

16 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norma R. Moore United Kingdom	12	248	214	171	159	148	16	834
Lesley M. Chapman United States	5	326 1.3×	93 0.4×	117 0.7×	65 0.4×	249 1.7×	5	972
Clara Luz Sampieri Mexico	16	88 0.4×	110 0.5×	413 2.4×	177 1.1×	363 2.5×	48	1.1k
Pascale E. P. Dekkers Netherlands	16	358 1.4×	388 1.8×	69 0.4×	131 0.8×	168 1.1×	34	1.2k
Marie Garvey Canada	21	638 2.6×	237 1.1×	54 0.3×	99 0.6×	109 0.7×	66	1.3k
Helen E. Rudloff United States	17	137 0.6×	308 1.4×	67 0.4×	231 1.5×	197 1.3×	25	1.4k
Howard Rj United States	14	186 0.8×	195 0.9×	45 0.3×	90 0.6×	91 0.6×	45	1.0k
Susan L. Heatley Australia	18	507 2.0×	312 1.5×	76 0.4×	140 0.9×	371 2.5×	51	1.7k
Yuka Torii Japan	16	67 0.3×	394 1.8×	109 0.6×	72 0.5×	221 1.5×	67	896
Masaaki Nagai Japan	17	41 0.2×	228 1.1×	55 0.3×	80 0.5×	262 1.8×	44	962
Gregory B. Pott United States	13	59 0.2×	267 1.2×	151 0.9×	245 1.5×	221 1.5×	24	1.0k

Countries citing papers authored by Norma R. Moore

Since Specialization

Citations

This map shows the geographic impact of Norma R. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma R. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma R. Moore more than expected).

Fields of papers citing papers by Norma R. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma R. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma R. Moore. The network helps show where Norma R. Moore may publish in the future.

Co-authorship network of co-authors of Norma R. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Norma R. Moore. A scholar is included among the top collaborators of Norma R. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma R. Moore. Norma R. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wilkinson, Thomas S., Andrew Conway Morris, Kallirroi Kefala, et al.. (2012). Ventilator-Associated Pneumonia Is Characterized by Excessive Release of Neutrophil Proteases in the Lung. CHEST Journal. 142(6). 1425–1432. 49 indexed citations

Mutch, Nicola J., et al.. (2007). The use of the Chandler loop to examine the interaction potential of NXY‐059 on the thrombolytic properties of rtPA on human thrombi in vitro. British Journal of Pharmacology. 153(1). 124–131. 18 indexed citations

Mutch, Nicola J., et al.. (2007). TAFIa, PAI‐1 and α2‐antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots. Journal of Thrombosis and Haemostasis. 5(4). 812–817. 98 indexed citations

Thomas, Louise, Norma R. Moore, Samantha Miller, & N. A. Booth. (2006). The C‐terminus of α₂‐antiplasmin interacts with endothelial cells. British Journal of Haematology. 136(3). 472–479. 12 indexed citations

Hellebrekers, Bart W.J., J.J. Emeis, Teake Kooistra, et al.. (2005). A role for the fibrinolytic system in postsurgical adhesion formation. Fertility and Sterility. 83(1). 122–129. 50 indexed citations

Mutch, Nicola J., et al.. (2003). Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI. Journal of Thrombosis and Haemostasis. 1(9). 2000–2007. 45 indexed citations

Moore, Norma R., et al.. (2003). Candida albicans binds human plasminogen: identification of eight plasminogen‐binding proteins. Molecular Microbiology. 47(6). 1637–1651. 198 indexed citations

Simpson, A. John, et al.. (1999). Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study. Acta Diabetologica. 36(3). 155–158. 11 indexed citations

Booth, N. A., et al.. (1998). Does chronic smoking influence fibrinolytic potential in Type 1 diabetes mellitus?. Diabetic Medicine. 15(8). 683–687. 6 indexed citations

10.

Simpson, Andrew J.G., et al.. (1997). THE EFFECTS OF CHRONIC SMOKING ON THE FIBRINOLYTIC POTENTIAL OF PLASMA AND PLATELETS. British Journal of Haematology. 97(1). 208–213. 73 indexed citations

11.

Jackson, Moira R., et al.. (1996). Enhanced cell-associated u-PA activity of endothelial cells in response to soluble factors released by human peripheral blood monocytes. Blood Coagulation & Fibrinolysis. 7(7). 728–728. 3 indexed citations

12.

Leiper, Keith, A Croll, N. A. Booth, et al.. (1994). Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.. Journal of Clinical Pathology. 47(3). 214–217. 36 indexed citations

13.

Booth, N. A., et al.. (1994). Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. International Journal of Gynecology & Obstetrics. 44(1). 96–96. 8 indexed citations

14.

Booth, N. A., et al.. (1993). Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in normal pregnancies, pre‐eclampsia and hydatidiform mole. BJOG An International Journal of Obstetrics & Gynaecology. 100(4). 370–374. 62 indexed citations

15.

Simpson, Andrew J.G., N. A. Booth, Norma R. Moore, & Bruce Bennett. (1991). Distribution of plasminogen activator inhibitor (PAI-1) in tissues.. Journal of Clinical Pathology. 44(2). 139–143. 130 indexed citations

16.

Simpson, A. John, Nuala A. Booth, Norma R. Moore, & Bruce Bennett. (1990). The platelet and plasma pools of plasminogen activator inhibitor (PAI‐1) vary independently in disease. British Journal of Haematology. 75(4). 543–548. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact